中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2011年
8期
568-573
,共6页
林齐防%陈万金%王柠%吴志英%林珉婷%慕容慎行
林齊防%陳萬金%王檸%吳誌英%林珉婷%慕容慎行
림제방%진만금%왕저%오지영%림민정%모용신행
假肥大型肌营养不良%Dystrophin基因%多重连接依赖性探针扩增%定量
假肥大型肌營養不良%Dystrophin基因%多重連接依賴性探針擴增%定量
가비대형기영양불량%Dystrophin기인%다중련접의뢰성탐침확증%정량
Duchenne/Becker muscular dystrophy%Dystrophin gene%MLPA%Quantitative studies
目的 应用多重连接依赖性探针扩增(MLPA)技术对假肥大型肌营养不良(DMD及BMD)患者及其家系成员进行dystrophin基因分析,探讨MLPA定量技术在本病重复突变及携带者检测中的优势.方法 以355例DMD及BMD患者、46名缺失型患者之母和8名重复型患者之母为研究对象,应用MLPA技术对dystrophin基因全长外显子进行分析,对于单一外显子缺失的样本采用PCR及测序进行验证.结果 经MLPA分析,全部355例患者中190例为dystrophin基因缺失型患者,在其余非缺失型患者中检测出34例重复型突变.此外,在46名缺失型患者的母亲中发现了28名携带者,在8名重复型患者的母亲中发现了6名携带者,两组患者母亲携带者频率差异无统计学意义.经过测序验证,在1例单一外显子缺失的患者中发现17号外显子存在AGGGAACAGATCCTGGTAAAGCA小片段缺失.结论 与传统的定量方法相比,MLPA定量技术可对DMD及BMD患者全长外显子区域同时进行缺失、重复分析,并能对患者家系成员的携带状态进行判定.此外,MLPA检测结果受模板DNA的浓度及纯度影响较小.
目的 應用多重連接依賴性探針擴增(MLPA)技術對假肥大型肌營養不良(DMD及BMD)患者及其傢繫成員進行dystrophin基因分析,探討MLPA定量技術在本病重複突變及攜帶者檢測中的優勢.方法 以355例DMD及BMD患者、46名缺失型患者之母和8名重複型患者之母為研究對象,應用MLPA技術對dystrophin基因全長外顯子進行分析,對于單一外顯子缺失的樣本採用PCR及測序進行驗證.結果 經MLPA分析,全部355例患者中190例為dystrophin基因缺失型患者,在其餘非缺失型患者中檢測齣34例重複型突變.此外,在46名缺失型患者的母親中髮現瞭28名攜帶者,在8名重複型患者的母親中髮現瞭6名攜帶者,兩組患者母親攜帶者頻率差異無統計學意義.經過測序驗證,在1例單一外顯子缺失的患者中髮現17號外顯子存在AGGGAACAGATCCTGGTAAAGCA小片段缺失.結論 與傳統的定量方法相比,MLPA定量技術可對DMD及BMD患者全長外顯子區域同時進行缺失、重複分析,併能對患者傢繫成員的攜帶狀態進行判定.此外,MLPA檢測結果受模闆DNA的濃度及純度影響較小.
목적 응용다중련접의뢰성탐침확증(MLPA)기술대가비대형기영양불량(DMD급BMD)환자급기가계성원진행dystrophin기인분석,탐토MLPA정량기술재본병중복돌변급휴대자검측중적우세.방법 이355례DMD급BMD환자、46명결실형환자지모화8명중복형환자지모위연구대상,응용MLPA기술대dystrophin기인전장외현자진행분석,대우단일외현자결실적양본채용PCR급측서진행험증.결과 경MLPA분석,전부355례환자중190례위dystrophin기인결실형환자,재기여비결실형환자중검측출34례중복형돌변.차외,재46명결실형환자적모친중발현료28명휴대자,재8명중복형환자적모친중발현료6명휴대자,량조환자모친휴대자빈솔차이무통계학의의.경과측서험증,재1례단일외현자결실적환자중발현17호외현자존재AGGGAACAGATCCTGGTAAAGCA소편단결실.결론 여전통적정량방법상비,MLPA정량기술가대DMD급BMD환자전장외현자구역동시진행결실、중복분석,병능대환자가계성원적휴대상태진행판정.차외,MLPA검측결과수모판DNA적농도급순도영향교소.
Objective To analyze the dystrophin gene in patients with Duchenne/Becker muscular dystrophy (DMD/BMD) and their family members by multiplex ligation-dependent probe amplification (MLPA) method and to evaluate the application of this method in the mutations detection. Methods The whole dystrophin gene (79 exons) was analyzed by MLPA in 355 patients with DMD/BMD, the mothers of 46 patients with deletion mutation and the mothers of 8 patients with duplication mutation. The results were verified by PCR and sequencing when single exon deletion was found. Results One hundred and ninety cases were found to have deletion of one or more dystrophin exons, and 34 patients were identified to have duplication mutations. In 46 mothers of patients with deletion mutations, 28 were identified the mutations;and of 8 mothers of patients with duplication mutations, 6 were identified the mutations. There was no statistical significance between the carrier incidences in the 2 groups. A 23 bp deletion of "AGGGAACAGATCCTGGTAAAGCA" fragment in exon 17 was found in a patient. Conclusions Comparing with the traditional quantitative methods, MLPA can detect the deletion and duplication mutation in all the 79 exons of dystrophin gene in DMD/BMD patients, and can identify the carrier status in their family members. Furthermore, MLPA is not apt to be interfered by the concentration and purity of DNA template.